Corrigendum to "Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity" [Mol Metab 78 (2023) 101801] - Martin Haljeta Friedrichsen; Lars Endahl; Frederik Flindt Kreiner; Ronald Goldwater; Martin Kankam; Søren Toubro; Sune Boris Nygård (Elsevier, 2024)